DEXCOM INC Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Dexcom Inc quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Dexcom Inc Return On Equity for the quarter ending June 30, 2024 was 29.6 %, a 71.5% increase year-over-year.
  • Dexcom Inc annual Return On Equity for 2023 was 25 %, a 53.8% increase from 2022.
  • Dexcom Inc annual Return On Equity for 2022 was 16.2 %, a 51.3% increase from 2021.
  • Dexcom Inc annual Return On Equity for 2021 was 10.7 %, a 72.6% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 29.6 +12.3 +71.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 29.5 +15.6 +113% Jan 1, 2024 Mar 31, 2024
Q4 2023 25 +8.74 +53.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 17.3 +5.52 +47% Jul 1, 2023 Sep 30, 2023
Q2 2023 17.3 +6.57 +61.5% Apr 1, 2023 Jun 30, 2023
Q1 2023 13.9 +1.53 +12.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 16.2 +5.51 +51.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 11.8 -20.5 -63.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 10.7 -23.6 -68.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 12.3 -23.3 -65.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 10.7 -28.4 -72.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 32.2 +12.4 +62.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 34.2 +13.4 +64.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 35.6 +17.5 +96.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 39.2 +25.7 +191% Oct 1, 2020 Dec 31, 2020
Q3 2020 19.8 +44.4 Jul 1, 2020 Sep 30, 2020
Q2 2020 20.8 +47.2 Apr 1, 2020 Jun 30, 2020
Q1 2020 18.1 +39.9 Jan 1, 2020 Mar 31, 2020
Q4 2019 13.5 +37.3 Oct 1, 2019 Dec 31, 2019
Q3 2019 -24.6 -33.8 -368% Jul 1, 2019 Sep 30, 2019
Q2 2019 -26.4 -25.1 -1987% Apr 1, 2019 Jun 30, 2019
Q1 2019 -21.9 -13.6 -164% Jan 1, 2019 Mar 31, 2019
Q4 2018 -23.9 -9.88 -70.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 9.17 +24 Jul 1, 2018 Sep 30, 2018
Q2 2018 -1.27 +20.8 +94.3% Apr 1, 2018 Jun 30, 2018
Q1 2018 -8.28 +24.7 +74.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -14 +11.7 +45.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -14.8 +8.77 +37.1% Jul 1, 2017 Sep 30, 2017
Q2 2017 -22.1 +14 +38.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -32.9 -1.63 -5.21% Jan 1, 2017 Mar 31, 2017
Q4 2016 -25.7 +5.75 +18.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -23.6 +11.8 +33.3% Jul 1, 2016 Sep 30, 2016
Q2 2016 -36.1 -21.8 -153% Apr 1, 2016 Jun 30, 2016
Q1 2016 -31.3 -13.2 -72.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -31.4 -11.3 -55.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -35.4 -8.35 -30.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -14.3 +16.8 +54.1% Apr 1, 2015 Jun 30, 2015
Q1 2015 -18.1 +20.8 +53.4% Jan 1, 2015 Mar 31, 2015
Q4 2014 -20.1 +19 +48.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -27.1 +20.9 +43.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -31.1 +30.9 +49.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -38.9 +25.2 +39.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -39.1 +23.6 +37.6% Oct 1, 2013 Dec 31, 2013
Q3 2013 -48 +14.1 +22.7% Jul 1, 2013 Sep 30, 2013
Q2 2013 -62 -8.83 -16.6% Apr 1, 2013 Jun 30, 2013
Q1 2013 -64.1 -21.2 -49.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -62.7 Oct 1, 2012 Dec 31, 2012
Q3 2012 -62.1 Jul 1, 2012 Sep 30, 2012
Q2 2012 -53.2 Apr 1, 2012 Jun 30, 2012
Q1 2012 -42.9 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.